FIELD: organic chemistry. SUBSTANCE: product: pyrimidine nucleosides of the formula (I) where R1 - H, CH3,; R2 - benzoyl, possibly substituted with Hal or alkoxy-group. Reagent 1: R2 unsubstituted nucleoside. Reagent 2: benzoyl chloride, possibly substituted. Reaction conditions: at the room temperature. Compounds show antiviral activity (on the herpes group). EFFECT: improved method of synthesis. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
SYNERGISTIC PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL COMPOSITION AND A METHOD OF TREATMENT OR PROPHYLAXIS OF HIV-INFECTION | 1992 |
|
RU2110993C1 |
METHOD OF SYNTHESIS OF SUBSTITUTED PURINE ARABINOSIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE DERIVATIVES | 1988 |
|
RU2039752C1 |
PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY AGAINST VIRAL INFECTION AND 9-β--D-ARABINOFURANOSYL-2-AMINO-6-METHOXY-9H-PURINES | 1993 |
|
RU2112765C1 |
METHOD OF INHIBITION OF HEPATITIS B VIRAL INFECTIONS | 1992 |
|
RU2116789C1 |
METHOD OF PRODUCING PYRIMIDINE NUCLEOSIDES | 0 |
|
SU1731064A3 |
ENANTIOMERIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1992 |
|
RU2091386C1 |
METHOD OF IMIDAZOPYRIDAZINES SYNTHESIS | 1989 |
|
RU2017741C1 |
METHOD OF HEPATITIS B TREATMENT | 1992 |
|
RU2104700C1 |
METHOD OF SYNTHESIS OF ENANTIOMERIC COMPOUNDS OR THEIR DERIVATIVES | 1990 |
|
RU2068849C1 |
PROCESS FOR PREPARING DERIVATIVES OF FLAVAN OR THEIR SALTS | 0 |
|
SU1072805A3 |
Authors
Dates
1995-05-27—Published
1989-05-26—Filed